PICC Line vs Central Line: Device Selection Guide
For critically ill ICU patients requiring short-term access (≤14 days), non-tunneled central venous catheters are preferred over PICCs; for intermediate-term access (15+ days) or peripherally compatible infusions, PICCs become appropriate, while tunneled catheters or ports are reserved for long-term use (≥31 days). 1
Duration-Based Selection Algorithm
Short-Term Access (≤5 days)
- PICC use is inappropriate for peripherally compatible infusions at this duration 1
- Non-tunneled CVCs are the appropriate choice for ICU patients 1, 2
- Nontunneled CVCs are designed specifically for continuous short-term (1-3 weeks) infusions, ranging from 5F to 14F 2
Intermediate Duration (6-14 days)
- For peripherally compatible infusions: Midline catheters and ultrasound-guided peripheral IVs are preferred over PICCs 1
- For critically ill patients: Non-tunneled CVCs remain preferred when skilled operators are available 1
- For vesicants/irritants (chemotherapy, parenteral nutrition): PICCs are appropriate at any duration 1
Extended Duration (15-30 days)
- PICCs become the preferred option over midline catheters due to risk of midline failure beyond 14 days 1
- Non-tunneled CVCs can be used for up to 3 weeks but carry higher infection rates (2.7 per 1,000 catheter-days vs 0.1 for ports) 2
Long-Term Access (≥31 days)
- Tunneled catheters or implanted ports are appropriate 1
- Ports have the lowest infection rates (0.1 per 1,000 catheter-days) 2
- Reserve these more invasive devices for when PICCs are not feasible or contraindicated 1
Key Advantages and Limitations
PICC Advantages
- Safer insertion in the arm with ultrasound guidance, avoiding pneumothorax and hemothorax risks 3
- Appropriate for patients with coagulopathy who need central access 3
- Cost-effective placement via vascular access teams 3
- Compatible with outpatient/home therapy 2
- Lower mechanical complication rates in some populations 4
PICC Limitations
- Higher deep venous thrombosis risk compared to traditional CVCs 5
- Not preferred in critically ill patients for short-term use 1
- Higher infection rates than tunneled devices (1.6 per 1,000 catheter-days for tunneled vs higher for non-tunneled) 2
- Lower flow rates may limit use in resuscitation scenarios (though power-injectable PICCs address this) 3
Non-Tunneled CVC Advantages
- Preferred for ICU patients requiring ≤14 days of access 1, 2
- Higher flow rates suitable for rapid infusions and hemodynamic monitoring 3
- Subclavian site associated with lower infection risk compared to jugular or femoral 2
- Appropriate for hemodialysis and apheresis 2
Non-Tunneled CVC Limitations
- Highest infection rates among central access devices (2.7 per 1,000 catheter-days) 2
- Risk of pneumothorax with subclavian insertion (though lower infection risk) 2
- Infection rates increase exponentially after 2-4 weeks 2
- Requires skilled operator for safe placement 1
Special Clinical Scenarios
Difficult Venous Access
- For ≤14 days: Ultrasound-guided peripheral IVs or midline catheters preferred over PICCs 1
- For ≥6 days: PICC insertion becomes appropriate 1
- For ≥31 days: Tunneled catheters are appropriate 1
Frequent Phlebotomy (≥3 times daily)
- For ≤5 days: Appropriateness uncertain; individualize after discussing risks/benefits 1
- For ≥6 days: PICC insertion is appropriate 1
- Non-tunneled CVCs appropriate if duration ≤14 days 1
Vesicant/Irritant Infusions
- PICCs are appropriate at any duration since peripheral access is contraindicated 1
- Non-tunneled CVCs appropriate for ≤14 days 1
- Tunneled catheters for ≥15 days, ports for ≥31 days 1
Critical Pitfalls to Avoid
Do not place PICCs for short-term use (≤5 days) in patients receiving peripherally compatible infusions—this represents inappropriate overuse 1. The evidence shows PICCs were rated inappropriate for this indication, yet practice patterns suggest they are frequently placed unnecessarily 1.
In ICU patients, avoid PICCs when non-tunneled CVCs are more appropriate for anticipated durations ≤14 days 1. The critically ill population benefits from the higher flow rates and more reliable access of centrally placed lines.
Consider infection risk by device type: Ports have dramatically lower rates (0.1 per 1,000 catheter-days) compared to non-tunneled CVCs (2.7 per 1,000 catheter-days) and tunneled catheters (1.6 per 1,000 catheter-days) 2. However, this must be balanced against the invasiveness of placement.
Use the smallest diameter catheter with minimum lumens necessary to minimize complications 2. Multilumen catheters increase infection risk but may be required for incompatible simultaneous infusions.